Table 2 SPER, DASPER, and RESPER for the top candidates with DASPER > 0 and RESPER > 1 across all prostate cancer tissue samples
From: FusionSeq: a modular framework for finding gene fusions by analyzing paired-end RNA-sequencing data
Type | ID | Fusion candidate | SPER | DASPER | RESPER |
|---|---|---|---|---|---|
Intra | 580_B | TMPRSS2-ERG | 36.54 | 36.53 | 14.31 |
Intra | 1700_D | TMPRSS2-ERG | 19.66 | 19.63 | 8.79 |
Intra | 106_T | TMPRSS2-ERG | 10.16 | 10.11 | 3.97 |
Inter | 2621_D | SLC45A3-ERG | 4.29 | 4.15 | 3.56 |
Inter | 1700_D | ERG-GMPR | 4.59 | 4.59 | 2.05 |
Read-through | 1700_D | SLC16A8-BAIAP2L2 | 4.33 | 4.33 | 1.93 |
Read-through | 106_T | AK094188-AK311452 | 4.87 | 4.87 | 1.9 |
Read-through | 1700_D | ZNF473-FLJ26850 | 3.54 | 3.54 | 1.58 |
Read-through | 580_B | ZNF577-FLJ26850 | 4.03 | 4.03 | 1.58 |
Read-through | 1043_D | ZNF577-ZNF649 | 5.79 | 5.79 | 1.55 |
Read-through | 1700_D | CAMTA2-INCA1 | 3.01 | 3.01 | 1.35 |
Inter | 1700_D | EEF1D-HDAC5 | 2.88 | 2.84 | 1.29 |
Read-through | 1043_D | FLJ00248-LRCH4 | 4.74 | 4.74 | 1.27 |
Read-through | 1700_D | VMAC-CAPS | 2.62 | 2.62 | 1.17 |
Read-through | 106_T | FLJ00248-LRCH4 | 2.96 | 2.96 | 1.16 |
Cis | 1043_D | AX747861-FLI1 | 4.21 | 4.21 | 1.13 |
Read-through | 106_T | TAGLN-AK126420 | 2.75 | 2.75 | 1.07 |
Inter | 580_B | PIGU-ALG5 | 2.73 | 2.73 | 1.07 |
Inter | 99_T | NDRG1-ERG | 7.26 | 7.15 | 1.02 |